HYGEIA INTERNATIONAL

Expansion in Nigeria is the issue. Henry Livingstone, vice president of the Africa/Middle East Region of Hygeia International, has just received a proposal from his Nigerian managing director for a major move into poultry production. This would extend hygeia’s profitable agricultural activities even more in that West African country.

CORPORATE BASE

HYGEIA International is pseudonym for one of the 10 leading pharmaceutical companies of the world. Based in the United States, hygeia also has laboratories and plants in many countries. Over a third of its net income is earned outside the U.S., and because of growing federal regulation, Hygeia looks abroad for a rising percentage of its future income. Like other large pharmaceutical films, Hygeia has converted drugs designed for humans to use in farm animals. This opens up a large market with relatively low R & D expense. In addition to veterinary products for the control and treatment of disease, hygeia produces a variety of feed supplements. Currently, about 15 percent of Hygeia’s total sales of over a billion dollars come from agricultural activities! Hygeia’s agricultural business includes active participation in mass production of poultry. Today, frying chickens are raised in 100,000-chick batches. Thanks to genetic selection. Scientific feeding, and a strictly controlled environment, fries can be ready for market in 10 weeks. Egg production is similarly engineered. Significantly, these mass production methods provide one of the most efficient conversions of cereal grains into protein known on earth. Of course, two essential features of such operations are drugs for disease control and feed supplements. Hygeia makes both (as do several competitors). More over, to keep contact with the latest developments, Hygeia has a subsidiary focusing on development of new genetic strains in